View all veterinary jobs
VetNurse.co.uk publishes a curated feed of veterinary nursing news for registered veterinary nurses (RVNs), students (SVNs) and veterinary nursing assistants, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest or professional significance — filtering out noise so busy veterinary nurses can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, referral and specialist settings, with a focus on issues affecting veterinary nurses in clinical and professional roles.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetNurse news by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The association says that its research has found that 94% of companion animal vets say they have clients who feed a raw diet, 42% who feed meat-free diets and 29% who feed insect-protein in place of meat.
However, 6 in 10 vets are unsure how many of the cats and dogs they see are fed meat-free diets.
In a new policy position, the BVA is now urging vets to talk to all cat and dog owners about what they feed their pet, and record nutritional histories and any resulting issues on their practice systems.
BVA President Anna Judson said: “We know that owners of cats and dogs are increasingly drawn to pet diets that reflect their own personal values and lifestyle choices, and this is leading to a surge in alternative approaches to pet food.
"We support owners making informed choices about what to feed their pets, but they must be aware that these choices play a pivotal role in the health of the animal and can also have a wider impact on human health and environmental sustainability.
“One of the key issues in these conversations is the lack of long-term, evidence-based research.
"If vet teams are to maintain our position as the ‘trusted voice’ in these conversations, it’s vital that we ask the right questions and also record as much data as possible so that we can understand the long-term impact of some of these newer diets.”
The BVA says its new policy position is not trying to dictate the ‘best’ diet for individual pets but to support pet owners in meeting their pets’ nutritional needs as well as meeting their own lifestyle choices.
The BVA is also recommending changes to veterinary education to include a new emphasis on the importance of nutrition in day one competencies for vets and nurses, and improved awareness of the need for supportive conversations with animal owners.
To support the profession, the BVA says it will create a new public facing resource and lobby for better labelling of pet food and better labelling and traceability of the animal by-products that represent one of the major sources of protein in many cat and dog foods.
Anna added: “The issues around pet food are complex and with so much information available to pet owners from breeders, friends, online forums and other sources, we want to support all members of the vet team to feel fully confident in guiding their clients through dietary decisions.
"We hope that these recommendations and our upcoming resources will improve the information available to both clients and vets, supporting owners to make healthy, informed choices for their pets.”
https://www.bva.co.uk/take-action/our-policies/diet-choices-for-cats-and-dogs
The researchers say that although increased appetite has been reported as a side effect of many AEDs in veterinary literature, the effect had not been quantified or studied in detail.
To assess the phenomenon in greater detail, the research team analysed food motivation through a validated Dog Obesity Risk Assessment questionnaire created by University of Cambridge1.
The study compared 222 dogs diagnosed with idiopathic epilepsy with a control population of 7,086 healthy dogs.
The survey was designed to determine if epilepsy and AEDs were associated with increased food motivation, weight gain and decreased activity, and to assess if and how caregivers managed weight gain in this population.
The data revealed that dogs with idiopathic epilepsy receiving AEDs had significantly higher food motivation in comparison to healthy dogs – they had increased interest in food, were less selective about food, were more interested in food between meals, and wanted more food than usually offered.
In response, carers of dogs on medication put greater effort into restricting how much their dogs ate, particularly of human food.
Despite this, these dogs had significantly greater fat mass.
More than half of owners of dogs with epilepsy always used treats to administer their dog’s ASD medication (53%) and did not compensate for it by reducing the dog’s main food ration (34%).
Given the epilepsy treatment often involves medication two or three times a day, this has the potential to increase calorie intake substantially, an issue compounded by epileptic dogs also being less active.
The researchers say it's important that vets and nurses advise owners to monitor their dog's weight and help them manage it.
Dr Anna Morros-Nuevo of the University of Cambridge, and primary author of this study, said: "Idiopathic epilepsy, and in particular seizure episodes, have such an overwhelming impact on these dogs' families that side effects such as weight gain often get overlooked, both by vets and the pet's families.
"But unfortunately, obesity has lifelong negative impact on health and quality of life, since it predisposes dogs to suffer from joint problems and respiratory diseases, as well as metabolic disorders and urinary incontinence.
"Obese dogs have also been shown to have a shorter lifespan than dogs with a normal weight.
"While ASD are non-negotiable for many of these dogs, their caregivers and veterinarians should be aware of the lifelong impact of their side effects and manage them carefully.
"We hope these findings will help to increase awareness for both veterinary professionals and dog carers of the side effects of ASD and their impact for the patient."
Reference
The Association says continuing uncertainty over the pandemic was the driving force behind the decision and it feels that a virtual Congress is the best option in 2021. The event will be held from Thursday 25th – Saturday 27th March.
Amanda Stranack, Chief Executive of the BSAVA, said: “A rich programme of content that makes full use of technology means attendees can still expect an event that brings together the veterinary professions for world-class CPD and the opportunity to network with delegates.
"Making this decision now means we can be sure there will be a safe and dedicated space for all our visitors, speakers, sponsors and exhibitors."
Manchester Central, the original venue for the 2021 Congress, is currently contracted as a Nightingale Hospital and that contract doesn’t conclude until 1st March 2021.
Amanda said: "While no one has a crystal ball, there is the possibility cases could increase over the winter and we cannot be certain the venue will be available to host our annual event.
"In order to ensure that delegates and exhibitors will have an excellent experience, moving Congress online is the most sensible option, without the need to worry about travel restrictions, or guidance that might change on a weekly basis.
"The positive is that without the need to travel Congress becomes accessible to a wider audience, with scope for more practitioners to attend more sessions. There’s a level of flexibility and convenience that’s just not possible with a physical event."
The BSAVA has partnered with a leading international provider of large-scale virtual conferences, tradeshows and exhibitions, with interactive elements facilitating one-to-one and group conversations.
The planned programme for 2021’s inaugural Manchester event is currently being repurposed for the virtual format, with a significant focus on ensuring the experience is as interactive as possible for each delegate.
Amanda said: “While we are deeply disappointed that we won’t, as a sector, be able to come together in person, we have made significant educational and financial investments in the online platform, to give us the tools to take the work we’ve been doing to deliver online CPD to the profession to a different level. We intend to make the most of that opportunity and provide a personalised experience, satisfy scientific curiosity and broaden horizons for all attendees.” Ian Ramsey, President of the BSAVA continued: “After months of lockdown, like many of our delegates, I was looking forward to meeting friends at the 2021 Congress at Manchester. Sadly, this is not to be, however BSAVA is going to be investing heavily in this project and I will be excited to welcome colleagues from the widest possible audience to what I think will be the best virtual small animal veterinary conference in the world. Of course, we are still also planning for a slow return to face- to-face events in the future when it is safe to do so, and more details will follow when there is greater clarity and confidence in physical events."
The Linnaeus OAPC initiative was launched in 2021 and originally allocated £30K for 2022.
However, that figure was doubled after the company received a growing number of high quality submissions.
33 papers were accepted for funding in 2022, of which 24 have so far been published and the remainder are undergoing peer review.
The authors comprise clinicians, specialists, residents and interns across nine referral and primary care sites within the group.
The OAPC was introduced by Professor Luisa De Risio, Clinical Research & Excellence Director at Linnaeus (pictured right).
She said: “By making clinical research open access, we can ensure it makes the widest possible impact – while also supporting the author’s profile and career development.
"We are continuing to offer OAPC funding to our associates in 2023 and look forward to seeing the fantastic research published as a result.”
Each 'Facing Up To Finances' discussion will include tips from a financial professional and live Q&A from the community.
Hosted by a member of VetYou, the panel will include a financial professional, a guest sharing their experience, and a member of the Veterinary Woman team.
Registrants can pre-submit questions or ask them live, including anonymously.
Editor of Veterinary Woman, Jenny Langridge, said: “Readers of Veterinary Woman ranked ‘finances’ as the top subject they needed to know more about to make the most of future opportunities.
"It’s vital that women in the veterinary professions are able to access trusted resources such as the Facing Up To Finances discussions to help achieve their financial goals.”
Further sessions in October 2024 and January and May 2025 will cover subjects including preparing for the unexpected, financial planning and negotiation around life moves such as family, moves and career shifts, and financial strategies for wellness and insurance.
https://www.subscribepage.com/veterinary_woman_finance_series
A team of researchers led by Tim Mair, CVS Equine Veterinary Director and Specialist in both Equine Internal Medicine and Equine Soft Tissue Surgery at Bell Equine Veterinary Clinic, will review 100 cases of colitis in adult horses and 100 controls referred to seven equine veterinary hospitals in the UK: five CVS equine veterinary hospitals as well as Rossdales Equine Hospital and University of Liverpool’s equine hospital.
A set of diagnostic tests on blood and faeces will be performed in these cases.
The laboratory tests will include: small redworm serology, culture and PCR of faeces for Salmonella spp, PCR of faeces for Clostridioides difficile and Clostridium perfringens, ELISA of faeces for toxins of C.difficile and C.perfringens, PCR of faeces for coronavirus.
The clinical features, laboratory results, treatments and outcomes will also be recorded.
Tim said: “Acute colitis accounts for around 5% of admissions to referral hospitals.
"And of those who are referred with it, half will not survive but there is very limited evidence available.
"So it’s vital that we build our evidence-base of this life-threatening condition.
"We hope that the outcomes of our new study will lead to a greater understanding of the causes and better inform veterinary treatment of colitis in UK adult horses.”
The Colitis in Adult Horses study is supported by a research grant from CVS, and funding for the small redworm ELISA will be given from Austin Davis Biologics.
The study started at the beginning of 2024 and the first horses have been recruited.
The results of the study are expected to be published in 2025.
The new product, which is for the management of any condition where eye health is supported by providing additional moisture or lubrication, is suitable for dogs, cats, horses, rabbits and other animals.
Oculeze contains glycerine (0.8%), Aloe vera, chamomile and propolis extract, the latter of which contains polyphenols which Millpledge says have been shown to support corneal health by multiple mechanisms of action including modulation of the tear film and a reduction in inflammation, apoptosis and oxidative stress1.
Millpledge says Oculeze lasts longer on the ocular surface than non-lipid lubricants2 because it evaporates more slowly3.
This prolonged action means fewer administrations, which should help client compliance.
Oculeze comes in two sizes - a 10 millilitre bottle and a pack of ten resealable 0.6 millilitre vials, suitable for short term use and travel.
The 10ml bottle includes a filter, preserving sterility for up to three months after opening.
Oculeze is available direct from Millpledge or from your usual wholesaler.
https://millpledge.com/shop/oculeze
sales@millpledge.com
The awards are to recognise outstanding veterinary practices that have demonstrated exceptional performance and innovation in areas crucial to the future success of the profession.
There are three categories: Leadership and Management Skills, Team and Self-Development, and Veterinary Start-Ups.
The three category winners will each win day and evening tickets to SPVS Congress 2025 on Thursday 30th January for three team members, plus overnight accommodation at the Hilton Birmingham Metropole.
Shortlisted practices will each win a book of their choice.
The deadline for submissions is Friday 18th October 2024.
https://spvs.org.uk/business-excellence-awards/
The streams for veterinary nurses will include six lectures on topics ranging from neurology to dentistry, along with guest speaker Hannah Donovan from Donovan Veterinary Behaviour to discuss behaviour in practice.
There will also be a speaker from Davies’ charity of the year: Vetlife.
Davies' hospital director Ben Orton said: “This is a high-level CPD and networking event aimed at our colleagues in the veterinary industry with a raft of advice and insight from some of the leading specialists here at Davies.
“Some of the topics covered include internal medicine, with EBVS European specialist in small animal internal medicine Katherine Clarke giving her expert opinion on chronic enteropathies with a focus on antibiotic prescribing.
“Head of anaesthesia Frances Downing will focus on anaesthesia and feline cardiomyopathies while head of physiotherapy Diane Messum will discuss a holistic approach to the osteoarthritis patient, so there will be plenty of stimulating and challenging content.”
The day-long event begins at 8.30am with arrival drinks and pastries before the morning session, which runs from 9am to 1.20pm.'
After an hour’s break for lunch and networking, the afternoon session will run from 2.20pm to 5pm.
That will be followed by a complimentary hog roast.
www.vetspecialists.co.uk/davies-congress-2024
The College says the online library, which is free to access, aims to encourage people to develop their leadership skills, regardless of what stage of their career they are at.
The Library has a range of materials that learners can work through at their own pace, including presentations, interviews, videos, blogs, articles and webinars on key leadership topics such as Delegation Skills, Difficult Conversations and Inclusive Leadership.
The RCVS Leadership Team will be adding more content to the library, and the profession will have opportunities to suggest topics that they would like to learn more about.
Gurpreet Gill, RCVS Leadership and Inclusion Manager, said: “In terms of veterinary CPD, importance often tends to be placed more on clinical and technical capabilities, but leadership skills are a critical aspect of every veterinary practice and organisation.
“It is also assumed that leadership is a condition of status or position, but this is not necessarily the case.
"Leadership is an everyday practice that is applicable to everyone, regardless of their role.
"The Leadership Library provides learning opportunities for anyone looking to develop and reflect on their leadership skills, which will also count towards the annual CPD requirement.”
The Leadership Library can be accessed now from https://www.rcvs.org.uk/lifelong-learning/rcvs-leadership-initiative/rcvs-leadership-library/
In the study: "Effects of human-animal interaction on salivary and urinary oxytocin in children and dogs1", oxytocin levels were recorded in 55 children and their pet dogs.
Oxytocin is associated with positive emotions, the reduction of stress and the formation of social bonds.
Oxytocin levels were tracked in both the children’s and dogs’ urine and saliva before and after they interacted.
Researchers say this is one of the first studies to examine the benefits of human animal interactions for both humans and dogs.
For the study, the children's oxytocin levels were measured when they interacted with their own pet dog, with an unfamiliar dog (a trained therapy dog), and when they engaged in solitary play.
The study found that:
The researchers concluded that the results support the hypothesis that oxytocin pathways may shape and respond to social interactions between children and dogs, highlighting an important role for companion animals in child development.
https://www.waltham.com/oxytocin-children-and-dogs
With contributions from 26 leading lights edited by Tanya Stephens, Eddie Clutton, Polly Taylor and Kathy L. Murphy, 'Veterinary Controversies and Ethical Dilemmas - Provocative Reflections on Clinical Practice' is pitched as being designed to 'stimulate undergraduate thought and discussion', and as a reference for practitioners coming to terms with life in a post-truth era.
That, however, is a massive undersell of the importance and value of this book, which should be required reading for everyone in the profession; not just veterinary surgeons, but nurses, regulators and RCVS Councillors, teachers, pharma companies, practice managers (including corporates) and veterinary receptionists, all of whom would benefit from an informed understanding of the most important issues facing the profession today.
There are too many subject areas in the book to list here, but some of the most eye-catching include the questions of:
It would be wrong to say that the veterinary profession is at a turning point. It has already turned. The question is whether it's heading in the right direction. This book provides a timely opportunity for everyone to reflect on that.
More practically, general practitioners should find this book hugely helpful in informing and shaping their own ethical positions on a variety of subjects, and to be able to express them to clients with more confidence, potentially with a real benefit to animal welfare.
The book is available direct from the publisher: https://www.routledge.com/Veterinary-Controversies-and-Ethical-Dilemmas-Provocative-Reflections-/Clutton-Murphy-Stephens-Taylor/p/book/9781032579863
Or from Amazon and all good bookstores: https://amzn.to/3LdCkbX
Photo: A gripping read.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
References
2021’s event will see over 70 hours of CPD across eight themes, with speakers including Megan Brashear and Helen Wilson, clinical lead for ECC at Langford Vets, University of Bristol.
RCVS President Mandisa Greene will open Congress with reflections from the past year. She'll be followed by the keynote speaker, Marie Holowaychuk, who will be sharing her knowledge and experience around health and wellbeing.
Dan Lewis – ECC specialist at Vets Now, who planned the veterinary Congress programme, said: “In 2020, the world of live events changed, and in November we delivered our first ECC virtual Congress to great success.
"Not only do we feel it is the right decision for everyone to continue our ECC Congress as a virtual event, but the format brings a huge number of opportunities for delegates, exhibitors and speakers, who joined us from all across the world.
"The interactive platform we’re using is cutting edge and it provides so much more than just webinars. Like last year, there will be live content, an interactive exhibition hall and more opportunities than ever for delegates to network and learn from some of the world’s leading veterinary experts discussing emergency and critical care.
"Our programme again this year has been carefully tailored to provide an inclusive learning experience for vets and vet nurses no matter what stage they’re at in their career, from students through to specialists.
"All being well, we will be back in Leeds for the ECC Congress in November 2022.” Full four-day tickets for delegates will range in price from £60 to £199 and ticket-holders will be able to access all the sessions on-demand for up to a month following the event.
To book your ticket, visit congress.vets-now.com
In addition to its Helpline service, Vetlife continued to provide mental health care through its Health Support service.
In 2023, the service facilitated 198 referrals, connecting individuals with mental health care resources.
The charity also provided over £100,000 of financial support to members of the profession who were facing financial hardship.
Trustee Danny Chambers MRCVS said: "Within the veterinary community, there is a profound sense that Vetlife belongs to all of us.
"With over 4000 of our friends and colleagues reaching out for support within just 12 months, we urgently need your assistance to ensure this invaluable service continues.
"By becoming a 'Friend of Vetlife' with a monthly contribution from just £2.10—less than the cost of a cup of coffee—you provide us with a steady, predictable income, enabling us to plan and deliver long-term, consistent support to our veterinary community."
https://www.vetlife.org.uk/become-a-vetlife-member
The journal provides free access to critical summaries of the best available evidence, called Knowledge Summaries, to help practitioners make informed evidence-based decisions in practice.
The new website has several new features, such as author and reviewer hubs, which contain information to guide contributors through the process of writing or reviewing papers for the journal.
A new ‘answer me’ button allows potential authors to pick a clinical query they are interested in answering and email it straight to the Editor, streamlining the process.
The new site also includes a new submission system, Editorial Manager, which streamlines the editorial process, communications with authors and reviewers, and the management of articles.
Kit Sturgess, Editor-in-Chief of Veterinary Evidence, says: “I am really excited by the new website; its look and functionality will significantly improve rapid access to information and further boost the engagement of the veterinary team with EBVM.
"After an impressive year for Veterinary Evidence, we have also moved to a new submission system, Editorial Manager, aimed at making the experience of submitting and reviewing papers easier and more efficient.
"Through the new website and publishing platform, the journal can get better metrics of how well we are supporting our readers, authors, and reviewers so we can use evidence to drive Quality Improvement.”
veterinaryevidence.org
The training, which is presented by Nicola Lakeman RVN, consists of seven bite-sized modules covering topics such as:
Kai Crawshaw, Brand Manager at Animalcare, said: "GI cases are among the most frequent reasons pet owners reach out to practices and often, these calls revolve around seeking advice on managing symptoms at home.
"This training will help veterinary receptionists and nurses gain the confidence and knowledge to handle these enquiries and ensure that pet owners receive prompt, accurate guidance."
The training is available on the BVRA website: www.bvra.co.uk.
Photo courtesy: https://depositphotos.com
The award categories are:
Nominations are welcome from both BSAVA members and non-members.
Nominations close on 30th October 2024 and the winners will be announced on 16th January 2025.
The BSAVA awards ceremony will take place at the reinvented Congress and Expo 2025, taking place at Manchester Central in March.
https://www.bsava.com/awards.
Movoflex contains eggshell membrane, hyaluronic acid, Astaxanthin, Boswellia serrata and krill meal, formulated to support joint health and help increase quality of life.
Virbac says that eggshell membrane, which has been shown to have an effect on mobility in dogs and humans1, contains a number of naturally occurring elements involved in joint structure and function, including collagen, glucosamine and chondroitin sulphate.
The company claims that one palatable Movoflex Soft Chew per day can lead to a perceived increase in mobility in 7 days 2, regardless of the activity levels or age of the dog.
This, the company says, compared to other supplements which can require multiple daily tablets to be given for up to six weeks before you start to see an effect.
Dan Johnson, Product Manager at Virbac said: ‘Movoflex Soft Chews offer pet owners an easy to give and reliable joint supplement, and as with all of Virbac’s joint health and mobility solutions, they are of the highest quality and developed based on science.’
Movoflex Soft Chews are available in Small (<15kg), Medium (15kg- 35kg) and Large Dog (35kg) packs, each containing 30 chews and are available to order from your usual veterinary wholesaler.
KISS (which stands for Knowledge, Information, Support and Sharing) will offer: In-Practice Training, The Hill’s Nutritional Ambassador Programme, On-Demand Education and Hill’s Webinars.
There will also be a variety of tailored training sessions designed to help give veterinary professionals the knowledge and tools to broach nutrition.
Michael Unsworth, Hill’s Vet Affairs Manager, UK & Republic of Ireland said: “Vet practices have gone above and beyond during the pandemic, supporting patients and owners alike during extremely challenging times Hill’s wants to extend a helping hand, with support, tips, and tools to stay a step ahead as pet parents return back into the clinic following months of looking out for their pet’s nutrition and wellbeing without the usual level of expert guidance and support from their veterinary team.
“Vets and their teams face multiple challenges on the pet nutrition front, whether it be the plethora of ‘self-appointed experts’ out there, trying to encourage loyalty from their clients, or the long-lasting effects of COVID, all of which are yet to play out over the long haul. The KISS initiative will provide clinics access to a dedicated team of passionate nutritional experts, ensuring vets have the right support and knowledge base - and one less thing to worry about as they strive to improve pets’ lives on a daily basis."
For more information, contact your Hill’s representative.
In the webinar, which is sponsored by Horiba, Ian will present an update on new exotic parasite infections and distribution across the UK and Europe, and what this means for pets, livestock and the people that care for them.
“New Exotic Parasites – Worming Their Way In?” is suitable for vets, nurses, students and veterinary care assistants.
https://horiba.link/4h2.
Backed by RJD Partners, the directors bought the company back from Benchmark Plc for a reported £12.75M after it decided to divest itself of all non-aquaculture-related assets.
Improve says that under its new leadership, it plans to expand its e-learning portfolio significantly, harnessing technologies like video teaching and virtual/augmented reality to offer a richer learning experience.
In collaboration with its assessment partner, the International School of Veterinary Postgraduate Studies (ISVPS), Improve will be developing new distance-learning programmes for veterinary nurses, including Anaesthesia and Surgical Nursing early in 2021.
Improve also plans further geographical expansion, including running programmes in languages including French, Spanish, German and Chinese.
Dr Heber Alves (pictured right) is Improve’s new CEO. He is supported by a management team that includes Improve founder Dr David Babington, Business Development Director and Mr John Douglass, UK Managing Director.
Heber said: “Improve is fully owned by a team of experienced veterinary and business professionals with a unique understanding of the profession’s training needs at a global level. Even better, we are backed by a private equity partner with a strong track record in professional education and a commitment to supporting our growth, both organically and through acquisition.
Available in packs of 56 (4 x 14 tablet blister packs), Lodisure tablets are divisible for accurate dosing.
The recommended starting dose is 0.125-0.25 mg amlodipine per kg bodyweight per day, which equates to half a tablet for cats weighing less than 4kg (and more than 2kg) and one tablet per day for cats weighing between 4kg and 8kg.
It can be administered directly to the cat or given with a small quantity of food.
Dechra companion animal brand manager, Sarah Musgrave, said: “Feline hypertension is very often part of a more complex diagnosis, therefore it is important that antihypertensive therapies are easy to dose and administer.
"Lodisure is a new, first-line, easy to dose and administer treatment to control systolic blood pressure in cats while the underlying primary cause is diagnosed and treated, which vets can rely on in their day-to-day practice.”
https://www.dechra.co.uk/products/cat/prescription/lodisure.
The app allows practices to submit results along with cytology and histopathology results in order to help train the AI algorithm and improve its accuracy from an original sensitivity of 85% and negative predictive value of 97%.
Liron Levy-Hirsch, Managing Director of HT Vista, said: “The HT app has provided us with over 700 additional validated scans to analyse this year alone.
"The validation process is well controlled, whereby we use the lab results to tag the scans as benign or malignant and let the algorithm know if it was correct or not.
"The more we train the algorithm the more accurate it becomes, and it is extremely exciting to see the sensitivity increase to 90% and the NPV to 98%.”
HT Vista says the app was developed to meet demand from clinics.
Liron said: "By having a portal to upload lab results alongside the device’s results not only do we further improve the device, but we also increase confidence among our vets and nurses that the device is a reliable tool.
https://ht-vista.uk
The company says AI Masses will allow veterinary professionals to analyse lesions suggestive of cancer in-clinic and with a fast turnaround.
The AI technology, which has been trained by human clinical pathologists, should enable individualised treatment outcomes earlier for more cases.
Zoetis says AI Masses only needs a single round of sample preparation and the results can, at additional cost, be supplemented with an expert review from a network of specialists through Zoetis’ Virtual Laboratory.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer at Zoetis said: “Waiting for results can be stressful for pet owners – even more so when it involves a cancer screening.
"Our research shows that up to 75% of pet owners find abnormal results highly stressful.1
"AI Masses is yet another point-of-care capability to deliver results in-clinic, further exemplifies Zoetis’ purpose to advance care for animals, shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome.”
Pre-orders will be announced for US customers in Q2 2025.
VetSurgeon.org understands AI Masses will be coming to the UK some time in 2025.
https://www.zoetisdiagnostics.com